8:32 am Idera Pharma announces agreement with Abbott (ABT) to develop a companion diagnostic for imo-8400 in genetically defined forms of b-cell lymphoma

8:32 am Idera Pharma announces agreement with Abbott (ABT) to develop a companion diagnostic for imo-8400 in genetically defined forms of b-cell lymphoma

more

View todays social media effects on IDRA

View the latest stocks trending across Twitter. Click to view dashboard

See who Idera is hiring next, click here to view

Share this post